Zdrowie i gospodarka · 18/03/2013

FDA Withdraws Approval of Bupropion Hydrochloride Extended-Release Tablets, 300 Milligrams, Citing Impax Laboratories' Request

The US Food and Drug Administration (FDA) has withdrawn approval of Bupropion Hydrochloride Extended-Release Tablets, 300 Milligrams, manufactured by Impax Laboratories, Inc., following the company's voluntary request to revoke the approval and waive a hearing process.